{
    "Trade/Device Name(s)": [
        "Sensititre\u00ae Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC susceptibility plates, for Tigecycline 0.004\u20138 \u03bcg/ml for Streptococcus spp."
    ],
    "Submitter Information": "TREK Diagnostic Systems, Inc.",
    "510(k) Number": "K062190",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JWY",
        "LRG"
    ],
    "Summary Letter Date": "July 26, 2006",
    "Summary Letter Received Date": "July 31, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Tigecycline"
    ],
    "Specimen Type(s)": [
        "Streptococcus spp. isolates"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Sensititre HP Susceptibility System"
    ],
    "Method(s)/Technology(ies)": [
        "MIC susceptibility testing"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Plate",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Sensititre HP MIC susceptibility plates for Tigecycline testing of Streptococcus spp. using the Sensititre HP Susceptibility System",
    "Indications for Use Summary": "In vitro diagnostic product for clinical susceptibility testing of fastidious organisms; addition of Tigecycline for testing Streptococcus spp. isolates",
    "fda_folder": "Microbiology"
}